Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

0ELV

Guerbet (0ELV)

Guerbet Sa
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0ELV
DateTimeSourceHeadlineSymbolCompany
24/07/202401:52UK RegulatoryGUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 juin 2024LSE:0ELVGuerbet Sa
18/03/202421:37UK RegulatoryGUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 29 février 2024LSE:0ELVGuerbet Sa
20/02/202403:46UK RegulatoryGUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 janvier 2024LSE:0ELVGuerbet Sa
12/12/202303:45PR Newswire (US)Guerbet announces marketing authorisation approval of Elucirem™ (Gadopiclenol) in the European UnionLSE:0ELVGuerbet Sa
22/09/202203:08PR Newswire (US)Guerbet announces U.S. Food and Drug Administration (FDA) approval of Elucirem™ (Gadopiclenol)LSE:0ELVGuerbet Sa
13/06/202216:30PR Newswire (US)Guerbet receives EMA acceptance of Elucirem™ as the Brand Name for GadopiclenolLSE:0ELVGuerbet Sa
08/03/202204:00PR Newswire (US)Guerbet expands portfolio with microcatheters and guidewires for interventional imaging and embolizationLSE:0ELVGuerbet Sa
08/03/202204:00PR Newswire (US)Guerbet expands portfolio with microcatheters and guidewires for interventional imaging and embolizationLSE:0ELVGuerbet Sa
 Showing the most relevant articles for your search:LSE:0ELV